相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immune and Inflammatory Mechanisms of Atherosclerosis
Elena Galkina et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Genetic and pharmacological inhibition of the 5-lipoxygenase/leukotriene pathway in atherosclerotic lesion development in ApoE deficient mice
Richard Yang Cao et al.
ATHEROSCLEROSIS (2009)
Hypercholesterolemia leads to elevated TGF-beta 1 activity and T helper 3-dependent autoimmune responses in atherosclerotic mice
Xinghua Zhou et al.
ATHEROSCLEROSIS (2009)
Anti-atherogenic effects of montelukast associated with reduced MCP-1 expression in a rabbit carotid balloon injury model
Song Ge et al.
ATHEROSCLEROSIS (2009)
Associations of genetic polymorphisms of arachidonate 5-lipoxygenase-activating protein with risk of coronary artery disease in a European-American population
Alexander K. Tsai et al.
ATHEROSCLEROSIS (2009)
Distinct parts of leukotriene C4 synthase interact with 5-lipoxygenase and 5-lipoxygenase activating protein
Tobias Strid et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Leukotriene Signaling in Atherosclerosis and Ischemia
Magnus Back
CARDIOVASCULAR DRUGS AND THERAPY (2009)
Leukotriene B4 enhances the activity of nuclear factor-kappa B pathway through BLT1 and BLT2 receptors in atherosclerosis
Eva Sanchez-Galan et al.
CARDIOVASCULAR RESEARCH (2009)
Involvement of Leukotriene Pathway in the Pathogenesis of Ischemia-Reperfusion Injury and Septic and Non-Septic Shock
Antonietta Rossi et al.
CURRENT VASCULAR PHARMACOLOGY (2009)
MK-886, an inhibitor of the 5-lipoxygenase-activating protein, inhibits cyclooxygenase-1 activity and suppresses platelet aggregation
Andreas Koeberle et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Differential inflammatory activity across human abdominal aortic aneurysms reveals neutrophil-derived leukotriene B4 as a major chemotactic factor released from the intraluminal thrombus
Xavier Houard et al.
FASEB JOURNAL (2009)
Dual 12/15-and 5-Lipoxygenase Deficiency in Macrophages Alters Arachidonic Acid Metabolism and Attenuates Peritonitis and Atherosclerosis in ApoE Knock-out Mice
Daniel Poeckel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Lymphotoxin β receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice
Rolf Graebner et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4
Akiko Maekawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Endothelial cysteinyl leukotriene 2 receptor expression mediates myocardial ischemia-reperfusion injury
Wei Jiang et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Anti-inflammatory and proresolving lipid mediators
Charles N. Serhan et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2008)
Variation in eicosanoid genes, non-fatal myocardial infarction and ischemic stroke
Rozenn N. Lemaitre et al.
ATHEROSCLEROSIS (2008)
Emigration of monocyte-derived cells to lymph nodes during resolution of inflammation and its failure in atherosclerosis
Gwendalyn J. Randolph
CURRENT OPINION IN LIPIDOLOGY (2008)
Human neutrophils convert the sebum-derived polyunsaturated fatty acid sebaleic acid to a potent granulocyte chemoattractant
Chantal Cossette et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
12/15-Lipoxygenase Regulates the Inflammatory Response to Bacterial Products In Vivo
Vincent Dioszeghy et al.
JOURNAL OF IMMUNOLOGY (2008)
Functional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors
Akiko Maekawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
ERK-mediated regulation of leukotriene biosynthesis by androgens: A molecular basis for gender differences in inflammation and asthma
Carlo Pergola et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Endothelial Cysteinyl Leukotriene 2 Receptor Expression and Myocardial Ischemia/Reperfusion Injury
Michael P. W. Moos et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2008)
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Charles N. Serhan et al.
NATURE REVIEWS IMMUNOLOGY (2008)
The potential link between atherosclerosis and the 5-lipoxygenase pathway:: investigational agents with new implications for the cardiovascular field
Carl Whatling et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Leukotrienes: Mediators that have been typecast as villains
N. Flamand et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Role of 5-lipoxygenase in myocardial ischemia-reperfusion injury in mice
Anna Adamek et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Angiotensin II-induced abdominal aortic aneurysm occurs independently of the 5-lipoxygenase pathway in apolipoprotein E-deficient mice
Richard Yang Cao et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2007)
5-Lipoxygenase:: regulation of expression and enzyme activity
Olof Radmark et al.
TRENDS IN BIOCHEMICAL SCIENCES (2007)
Inhibited aortic aneurysm formation in BLT1-deficient mice
Neil Ahluwalia et al.
JOURNAL OF IMMUNOLOGY (2007)
Assessment of in vivo 5-lipoxygenase activity by analysis of leukotriene B4 in saliva:: Effects of treatment with zileuton
Flora Gaber et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Regulation of 5-hydroxyeicosanoid dehydrogenase activity in monocytic cells
Karl-Rudolf Erlemann et al.
BIOCHEMICAL JOURNAL (2007)
Leukotriene receptors:: Crucial components in vascular inflammation
Magnus Back
THESCIENTIFICWORLDJOURNAL (2007)
Licofelone, a balanced inhibitor of cyclooxygenase and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis
Cristina Vidal et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Resolution phase of inflammation: Novel endogenous anti-inflammatory and proresolving lipid mediators and pathways
Charles N. Serhan
ANNUAL REVIEW OF IMMUNOLOGY (2007)
Plaque stabilization: Can we turn theory into evidence?
Peter Libby et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor
Paolo Ciana et al.
EMBO JOURNAL (2006)
Spatio-temporal properties of 5-lipoxygenase expression and activation in the brain after focal cerebral ischemia in rats
Yu Zhou et al.
LIFE SCIENCES (2006)
Inflammation and immune regulation by 12/15-lipoxygenases
Hartmut Kuehn et al.
PROGRESS IN LIPID RESEARCH (2006)
Differential induction of BLT receptor expression on human endothelial cells by lipopolysacharide, cytokines, and leukotriene B4
H Qiu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Cysteinyl leukotriene 2 receptor and protease-activated receptor 1 activate strongly correlated early genes in human endothelial cells
B Uzonyi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Inhibition of five lipoxygenase activating protein (FLAP) by MK-886 decreases atherosclerosis in apoE/LDLR-double knockout mice
J Jawien et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2006)
Leukotriene receptors in atherosclerosis
Magnus Back et al.
ANNALS OF MEDICINE (2006)
CysLT1 receptor is a target for extracellular nucleotide-induced heterologous desensitization:: a possible feedback mechanism in inflammation
V Capra et al.
JOURNAL OF CELL SCIENCE (2005)
Leukotriene B4 signaling through NF-κB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia
M Bäck et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Leukotriene modifiers as potential therapeutics for cardiovascular disease
CD Funk
NATURE REVIEWS DRUG DISCOVERY (2005)
Association between 5-lipoxygenase expression and plaque instability in humans
F Cipollone et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Inhibition of atherogenesis in BLT1-deficient mice reveals a role for LTB4 and BLT1 in smooth muscle cell recruitment
EA Heller et al.
CIRCULATION (2005)
Pro- and anti-inflammatory substances modulate expression of the leukotriene B4 receptor, BLT1, in human monocytes
A Pettersson et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Biochemistry, biology and chemistry of the 5-lipoxygenase product 5-oxo-ETE
WS Powell et al.
PROGRESS IN LIPID RESEARCH (2005)
Cerebral ischemia in 5-lipoxygenase knockout mice
K Kitagawa et al.
BRAIN RESEARCH (2004)
Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway
CL Karp et al.
NATURE IMMUNOLOGY (2004)
The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke
A Helgadottir et al.
NATURE GENETICS (2004)
Mouse models of abdominal aortic aneurysms
A Daugherty et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Leukotriene B4 strongly increases monocyte chemoattractant protein-1 in human monocytes
L Huang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm
L Zhao et al.
NATURE MEDICINE (2004)
Reduction of renal ischemia-reperfusion injury in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton
NSA Patel et al.
MOLECULAR PHARMACOLOGY (2004)
Th2-predominant inflammation and blockade of IFN-γ signaling induce aneurysms in allografted aortas
K Shimizu et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Directed vascular expression of human cysteinyl leukotriene 2 receptor modulates endothelial permeability and systemic blood pressure
YQ Hui et al.
CIRCULATION (2004)
From vulnerable plaque to vulnerable patient - A call for new definitions and risk assessment strategies: Part II
M Naghavi et al.
CIRCULATION (2003)
From vulnerable plaque to vulnerable patient - A call for new definitions and risk assessment strategies: Part I
M Naghavi et al.
CIRCULATION (2003)
Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice
K Saraff et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Differential leukotriene receptor expression and calcium responses in endothelial cells and macrophages indicate 5-lipoxygenase-dependent circuits of inflammation and atherogenesis
K Lötzer et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis
R Spanbroek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Opposing effects of 15-lipoxygenase-1 and-2 metabolites on MAPK signaling in prostate -: Alteration in peroxisome proliferator-activated receptor γ
LC Hsi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4
BD Levy et al.
NATURE MEDICINE (2002)
Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice
M Mehrabian et al.
CIRCULATION RESEARCH (2002)
Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice
RJ Aiello et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Cyclooxygenase-2-issued prostaglandin E-2 enhances the production of endogenous IL-10, which down-regulates dendritic cell functions
H Harizi et al.
JOURNAL OF IMMUNOLOGY (2002)
Mouse strain-dependent chemokine regulation of the genital tract T helper cell type 1 immune response
T Darville et al.
INFECTION AND IMMUNITY (2001)
Prostaglandins and leukotrienes: Advances in eicosanoid biology
CD Funk
SCIENCE (2001)
Genetic locus in mice that blocks development of atherosclerosis despite extreme hyperlipidemia
M Mehrabian et al.
CIRCULATION RESEARCH (2001)
Leukotriene B4:: Metabolism and signal transduction
T Yokomizo et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2001)
The leukotriene C4 transporter MRP1 regulates CCL19 (MIP-3β, ELC)-dependent mobilization of dendritic cells to lymph nodes
DF Robbiani et al.
CELL (2000)
Monoclonal anti-CD18 antibody prevents transcellular biosynthesis of cysteinyl leukotrienes in vitro and in vivo and protects against leukotriene-dependent increase in coronary vascular resistance and myocardial stiffness
A Sala et al.
CIRCULATION (2000)
Leukotrienes in caudiovascular diseases
G Folco et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Lipoxygenase inhibitor FLM 5011, an effective protectant of myocardial microvessels against ischemia-reperfusion injury? An ultrastructural-morphometric study
K Welt et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2000)
分享论文
